575 filings
Page 3 of 29
6-K
3f7w0lgbl1k313y1kj
3 Aug 22
Aeterna Zentaris Reports Second Quarter 2022 Financial Results and Recent Highlights
5:27pm
6-K
qfy7zu1xw9
3 Aug 22
Condensed Interim Consolidated Financial Statements
5:14pm
6-K
zd2xak9upvnnnwarhh
26 Jul 22
Material Change Report
3:49pm
6-K
qo32ep2p2aa6
19 Jul 22
Current report (foreign)
4:52pm
6-K
o6044wk
18 Jul 22
Aeterna Zentaris Announces Effective Date of Share Consolidation
5:29pm
6-K
x48cj70egd wyxh6zuz
15 Jul 22
Current report (foreign)
4:15pm
6-K
gm1ze1x
6 Jul 22
Aeterna Zentaris Announces Further Adjournment of Shareholder Meeting
4:05pm
6-K
lcjz9b6m
21 Jun 22
Aeterna Zentaris Announces Results of Annual Meeting of Shareholders
4:12pm
6-K
itjiizo9lqn33k63kz
21 Jun 22
Report of Voting Results
4:04pm
6-K
ds5dv 80169qptgu8w0p
31 May 22
Annual General and Special Meeting of Shareholders
6:12am
6-K
ms3syownymbiqyq0
17 May 22
Current report (foreign)
3:04pm
6-K
4s8ww
16 May 22
Aeterna Zentaris Announces Virtual 2022 Meeting of Shareholders and Urges Shareholders to Vote in Favor of the Proposed Share Consolidation
2:14pm
6-K
wl4w ytit
11 May 22
Aeterna Zentaris Reports First Quarter 2022 Financial Results and Provides Business Outlook
7:48pm
6-K
gaiccrvotvj39l
10 May 22
Current report (foreign)
7:18pm
6-K
syn2d wphwy52
19 Apr 22
Aeterna Zentaris Secures New European Patent Related to Use of Macimorelin for the Diagnosis of Growth Hormone Deficiency in Adults
8:45pm
6-K/A
0ggmesr2 5yy2d0
31 Mar 22
Consolidated Financial Statements
4:05pm
6-K
6vfiirirxidrc8avk1
29 Mar 22
Aeterna Zentaris Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Outlook
8:10am
6-K
qo36zrs4g9c7c31o 3sl
28 Mar 22
Consolidated Financial Statements
9:35pm
6-K
pwvm dy78
10 Mar 22
Current report (foreign)
6:21pm
6-K
awkjz
2 Mar 22
Aeterna Zentaris Announces Notice of Allowance for U.S. Patent Covering AEZS-150 for the Potential Treatment of Chronic Hypoparathyroidism
8:15am